Can early-stage liver cirrhosis caused by hepatitis B be cured?
Aug 24, 2022
Source: Cainiu Health
Dr. Jin Zhongkui
Introduction
Early-stage hepatitis B-related cirrhosis can be reversed. The treatment goal is to suppress hepatitis B virus (HBV) DNA to below the lower limit of detection and maintain normal liver function test results. If liver function is abnormal in early-stage hepatitis B-related cirrhosis, hepatoprotective therapy is required to restore liver function to normal. If HBV DNA levels remain high in early-stage hepatitis B-related cirrhosis, effective antiviral therapy is necessary.
Liver cirrhosis is a common disease in daily life. As we all know, the earlier a disease is detected, the better the treatment outcome—and the greater the likelihood of successful treatment. Liver cirrhosis is no exception. Many people neglect their health, failing to pay attention to early warning signs; by the time symptoms become severe, they regret having delayed treatment. So, can early-stage hepatitis B-related cirrhosis be cured?
Can early-stage hepatitis B-related cirrhosis be cured?
Early-stage hepatitis B-related cirrhosis can be effectively managed and, in many cases, achieve clinical cure. The treatment criteria include: hepatitis B virus (HBV) DNA levels falling below the lower limit of detection, and sustained normalization of liver function tests. If liver function is abnormal in early-stage hepatitis B-related cirrhosis, hepatoprotective therapy is required to restore normal liver function. When HBV DNA levels are elevated in early-stage disease, effective antiviral therapy is essential—and HBV DNA must be suppressed below the detectable limit. Achieving both normal liver function and undetectable HBV DNA indicates clinical cure, which does not adversely affect the life expectancy of patients with early-stage hepatitis B-related cirrhosis.
With appropriate treatment, progression of early-stage hepatitis B-related cirrhosis can be halted. However, the structural changes of early cirrhosis—such as fibrosis and nodule formation—typically cannot be fully reversed to a completely normal liver architecture, nor can HBV be completely eradicated. Therefore, from a strict anatomical and virological standpoint, “complete cure” is generally not achievable. Currently, under physician guidance, oral nucleos(t)ide analogues—most commonly entecavir or tenofovir—are used to suppress viral replication to extremely low levels. This prevents ongoing HBV-induced liver damage, allows partial repair of early cirrhotic changes, halts further progression, and prevents transition to decompensated cirrhosis.
Patients are advised to maintain healthy lifestyle habits, avoid spicy and irritating foods, and follow a balanced diet. We hope this information is helpful to you.
